Covista Inc (CVSA) Stock Analysis
Verdict: BUY
Strong FCF and healthcare demand bridge the gap between a liquidity-strained balance sheet and premium sector valuation.
Investment score: 68/100
Analysis as of
Is Covista Inc stock worth reviewing? AI model thesis
Buy cvsa for superior FCF yield and margin profile relative to education peers, following a technical-driven price reset.
7-factor investment score
- Valuation: 75/100 (weight 20%)
- Financial Health: 70/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 85/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 72/100 (weight 15%)
Covista Inc opportunities and risks
What speaks for CVSA
- Superior FCF Generation
What speaks against CVSA
- Liquidity and Short-term Solvency Pressures
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CVSA | 16.9x | 2.1x | 10.7x | 57.3% | 12.3% | 8.3% |
| DUOL | 14.2x | 5.5x | 23.1x | 72.1% | 38.4% | 6.8% |
| LAUR | 20.1x | 3.0x | 11.2x | 26.9% | 16.1% | 5.0% |
| GHC | 17.3x | 1.0x | 9.2x | 28.5% | 6.0% | 5.6% |
| BFAM | 22.3x | 1.3x | 13.8x | 23.5% | 6.4% | 6.9% |
| LOPE | 17.6x | 3.3x | 11.5x | 53.3% | 19.5% | 6.9% |
| Peer median | 17.6x | 3.0x | 11.5x | 28.5% | 16.1% | 6.8% |
Frequently asked questions about Covista Inc (CVSA)
Is CVSA stock a good investment?
The cached TradeMates AI model rates Covista Inc as BUY with an investment score of 68/100. Buy cvsa for superior FCF yield and margin profile relative to education peers, following a technical-driven price reset. This is algorithmic model output, not personal investment advice.
Is CVSA stock a buy?
The TradeMates model verdict for CVSA is BUY with an investment score of 68/100. Treat this as a model signal to review, not a personal buy recommendation.